4SC announces positive top line results from Phase II SAPHIRE trial with Resminostat
by on Tuesday, September 6th, 2011 | No Comments
… SAPHIRE trial with resminostat, its oral pan HDAC inhibitor, in patients with relapsed/refractory Hodgkin’s Lymphoma (HL). If you want to view the full text, you must first …
View post: 4SC announces positive top line results from Phase II SAPHIRE trial with Resminostat
